← SynDRA
VIDOFLUDIMUS
SynDRA canonical compound SYN0005946 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | IL17A |
| Mechanism of action | Dihydroorotate dehydrogenase inhibitor |
All known targets
Mechanisms of action (all sources)
- Dihydroorotate dehydrogenase inhibitor
- DHODH INHIBITOR
- NR4A2 ACTIVATOR
- DHODH MODULATOR
Cross-references
Synonyms
- IMU-838
- 4SC-101
- NSC-717824
- SC-12267
- SC12267
- UNII-8Y1PJ3VG81
- Vidofludimus(4SC-101
- SC12267)
- CHEMBL197194
- 8Y1PJ3VG81
- 2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic Acid
- 2-{[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl}cyclopent-1-ene-1-carboxylic acid
- 2-[[2-fluoranyl-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid
- Vidofludimus [INN]
- SC 12267
- SCHEMBL247888
- GTPL9860
- KS-00000TTT
- BDBM16111
- EX-A546
- DTXSID50431325
- MolPort-039-193-851
- BCP14555
- AOB87354
- s7262
- ZINC14960644
- vidofludimusum
- RefChem:934024
- DTXCID60382157
- 4sc-101;SC12267
- Vidofludimus(4SC-101; SC12267)
- MFCD18633262
- Vidofludimus (USAN/INN)
- VIDOFLUDIMUS [USAN]
- VIDOFLUDIMUS [WHO-DD]
- orb1305278
- SCHEMBL29352865
- IMU-838 (vidofludimus calcium)
- GLXC-90163
Look up VIDOFLUDIMUS in the interactive SynDRA portal →